Evidence map›Paper›PMID 42236949›Full record

ArticleNature2026

Cell-type-resolved genetic variation shapes inflammatory bowel disease risk.

Tobi Alegbe, Bradley T Harris, Laura Fachal, Lucia Ramirez-Navarro, Marcus Tutert, Monika Krzak, Mennatallah Ghouraba, Michelle Strickland, Matiss Ozols, Celeste E Cohen and 27 more

Abstract read
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Genetic Risk Meets the Intestinal Barrier.Immunology and cell biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Exome sequencing directly implicates 68 genes in inflammatory bowel disease.medRxiv : the preprint server for health sciences · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Tobi Alegbe *Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0003-1622-0502
Bradley T Harris *Wellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-9585-1016
Laura FachalWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-7256-9752
Lucia Ramirez-NavarroWellcome Sanger Institute, Hinxton, UK.
Marcus TutertWellcome Sanger Institute, Hinxton, UK.
Monika KrzakWellcome Sanger Institute, Hinxton, UK.
Mennatallah GhourabaWellcome Sanger Institute, Hinxton, UK.
Michelle StricklandWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-8053-400X
Matiss OzolsWellcome Sanger Institute, Hinxton, UK.
Celeste E CohenWellcome Sanger Institute, Hinxton, UK.
Saniya KhullarWellcome Sanger Institute, Hinxton, UK.
Eleonora KhabirovaWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-5891-6789
Nikolaos I PanousisGlaxoSmithKline, Stevenage, UK.
David OchoaOpen Targets, Hinxton, UK.ORCID http://orcid.org/0000-0003-1857-278X
Noor WanaWellcome Sanger Institute, Hinxton, UK.
May Xueqi HuWellcome Sanger Institute, Hinxton, UK.
Jason SkeltonWellcome Sanger Institute, Hinxton, UK.
Jasmin OstermayerWellcome Sanger Institute, Hinxton, UK.
Kimberly Ai Xian CheamWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0009-0005-8842-141X
D Leland TaylorWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-6498-6970
Yong GuWellcome Sanger Institute, Hinxton, UK.
Claire DawsonAddenbrooke's Hospital, Cambridge, UK.
Tina ThompsonAddenbrooke's Hospital, Cambridge, UK.
Kenneth ArestangAddenbrooke's Hospital, Cambridge, UK.
Nilanga NishadAddenbrooke's Hospital, Cambridge, UK.
Biljana BrezinaAddenbrooke's Hospital, Cambridge, UK.ORCID http://orcid.org/0000-0001-5060-5604
Charry Queen CaballesAddenbrooke's Hospital, Cambridge, UK.
Wendy GarriAddenbrooke's Hospital, Cambridge, UK.
Steven LeonardWellcome Sanger Institute, Hinxton, UK.
Vivek IyerWellcome Sanger Institute, Hinxton, UK.
Miles ParkesAddenbrooke's Hospital, Cambridge, UK.ORCID http://orcid.org/0000-0002-6467-0631
Chris WallaceDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-9755-1703
Rebecca E McIntyreWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0001-5291-1533
Cristina Cotobal MartinWellcome Sanger Institute, Hinxton, UK.ORCID http://orcid.org/0000-0002-5877-2228
Gareth-Rhys JonesUniversity of Edinburgh Centre for Inflammation Research, Queens Medical Research institute, Edinburgh, UK.
Tim RaineOpen Targets, Hinxton, UK. tim.raine@nhs.net.ORCID http://orcid.org/0000-0002-5855-9873
Carl A AndersonWellcome Sanger Institute, Hinxton, UK. ca3@sanger.ac.uk.ORCID http://orcid.org/0000-0003-1719-7009

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most genetic variants associated with complex diseases lie in non-coding regions

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyInflammatory Bowel DiseasesQuantitative Trait LociEnhancer Elements, GeneticFemaleGene Expression RegulationGenetic VariationHumansIntestinal Barrier FunctionIntestinesMyeloid CellsOrgan SpecificityReceptors, NotchSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisReceptors, Notch

Identifiers

PMID42236949
PMCPMC13441992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.